Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 578       
ORIGINAL ARTICLE
Year : 2014  |  Volume : 139  |  Issue : 6  |  Page : 913-920

Production of a compound against methicillin resistant Staphylococcus aureus (MRSA) from Streptomyces rubrolavendulae ICN3 & its evaluation in zebrafish embryos


1 Centre for Nanoscience & Nanotechnology (CNSNT), Sathyabama University, Chennai; International Centre for Nanobiotechnology, Centre for Marine Science & Technology, Manonmaniam Sundaranar University, Rajakkamangalam, India
2 International Centre for Nanobiotechnology, Centre for Marine Science & Technology, Manonmaniam Sundaranar University, Rajakkamangalam, India

Correspondence Address:
Samuel Gnana Prakash Vincent
Coordinator, International Centre for Nanobiotechnology (ICN) Centre for Marine Science & Technology (CMST), Manonmaniam Sundaranar University Rajakkamangalam 629 502, Kanyakumari District, TN
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 25109726

Rights and PermissionsRights and Permissions

Background & objectives: Antibiotic resistance in pathogens has become a serious problem worldwide. Therefore, the search for new antibiotics for drug resistanct pathogens is an important endeavor. The present study deals with the production of anti-methicillin resistant Staphylococcus aureus (MRSA) potential of Streptomyces rubrolavendulae ICN3 and evaluation of anti-MRSA compound in zebrafish embryos. Methods: The antibiotic production from S. rubrolavendulae ICN3 was optimized in solid state fermentation and extracted. The antagonistic activity was confirmed against MRSA and purified in silica gel column and reverse phase - HPLC with an absorption maximum at 215 nm. Minimal inhibitory concentration of the compound was determined by broth microdilution method. Zebrafish embryos were used to evaluate the extract/compound for its minimal inhibition studies, influences on heart beat rates, haematopoietic blood cell count and lethal dose values. Results: Streptomyces rubrolavendulae ICN3 showed potent antagonistic activity against MRSA with a zone of 42 mm. The minimum inhibitory concentration was calculated as 500 μg/ml of the crude extract and the purified C23 exhibited 2.5 μg/ml in in vitro assay. The LC 50 value of the anti MRSA compound C23 was calculated as 60.49 μg/ml and the MRSA treated embryos survived in the presence of purified compound C23 at a dose of 10 μg/ml. Interpretation & conclusions: Our results suggested that the compound was potent with less toxic effects in zebrafish embryonic model system for MRSA infection. Further structural evaluation and analysis in higher mammalian model system may lead to a novel drug candidate for drug resistant Staphylococcus aureus.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1095    
    Printed23    
    Emailed0    
    PDF Downloaded391    
    Comments [Add]    

Recommend this journal